leisure time -WSS

leisure time

author：explore 2025-09-29 01:09:32 - browse：23239

Pfizer is this year’s anti-Eli Lilly. If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourlais, unfortunately, the worst.

My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels. That’s not why Bourla is here. The reason is accountability. Strategic missteps, financial miscalculations, and scientific setbacks have plunged Pfizer into a deep crisis. Bourla is the man at the top, so the responsibility lies with him.

Pfizer shares have fallen 50% this year to their lowest level in more than a decade, erasing nearly $140 billion in market value. In 2022, the company delivered $100 billion in revenue, boosted by a widely used Covid vaccine and Covid treatment. This year, Covid product sales evaporated — and will fall further next year — leaving a vacuum Pfizer is struggling to fill with aging medicines nearing the end of their patent lives, and newer drugs and vaccines that have not performed as expected.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Immune cells and nerve overgrowth may explain recurring UTI pain

WSS

The untold story of TV’s first prescription drug ad

Change Healthcare cyberattack affects 25% of CVS/Aetna insurance claims

Adults seen as increasingly susceptible to measles

The high personal cost of affirmative action for Black doctors

Amazon expands telehealth clinic nationwide

Medicare drug price negotiation continues, as pharma counteroffers

entertainment

leisure time

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Micronoma's microbiome cancer diagnostic approach under fire

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Micronoma's microbiome cancer diagnostic approach under fire

Virginia high school admissions case could be legal follow

Fetal cell organoids grown from amniotic fluid, study finds

Guidelines to prevent youth baseball injuries need more muscle

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The high personal cost of affirmative action for Black doctors

explore

Readout Newsletter: The latest on Novo Nordisk, Alnylam, Apogee

New safety details link Apellis eye drug to rare cases of blindness

EQRx, failed developer of low

Lawsuit alleges UnitedHealth Group unit illegally denied claims

Harvard's David Sinclair gets blowback over aging

He's 19 months old and has one of the world’s rarest diseases

focus

explore

focus

leisure time